- Hilary Pinnock, senior clinical research fellow
- 1Allergy and Respiratory Research Group, Division of Community Health Sciences: GP Section, University of Edinburgh, Edinburgh EH8 9DX
- hilary.pinnock{at}ed.ac.uk
A 38 year old office worker who had recently taken up jogging as part of a fitness campaign presented to you because his efforts had not proved as successful as he had hoped. He reported a history of asthma since childhood and still had occasional symptoms throughout the year, although normally he was troubled by his wheezing only for a few weeks after viral upper respiratory tract infections. He was being prescribed beclometasone 100 μg regularly twice a day and salbutamol as needed to relieve symptoms. It had been two years since he last had a course of steroids to treat an acute exacerbation.
He had set himself the long term goal of running for an hour after work every day, but had had to curtail his phased exercise programme because of shortness of breath. Using his salbutamol inhaler before running had some effect but was not preventing the problem.
Questions
1. How would you approach the problem?
2. What treatment choices would you offer the patient?
3. How would you help him self manage his condition?
Answers
Short answers
1. Before suggesting stepping up treatment, go back to basics. Clarify that asthma is the cause of his symptoms (he may just be unfit), ask about smoking status, explore compliance, check his inhaler technique, ask about rhinitis, and consider possible triggers.
2. Once you have established that he has exercise induced symptoms related to seasonal loss of his usually good asthma control and have dealt with any problems of compliance or inhaler technique, you may follow the guideline from the British Thoracic Society-Scottish Intercollegiate Guideline Network, which recommends adding a long acting β2 agonist as first line strategy.1 Other options include increasing the dose of inhaled steroids, adding a leucotriene receptor antagonist, or combining the long acting β2 agonist and inhaled corticosteroid in …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record

CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012